Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells

Despite the benefits associated with radiotherapy and chemotherapy for glioblastoma (GBM) treatment, most patients experience a relapse following initial therapy. Recurrent or progressive GBM usually does not respond anymore to standard therapy, and this is associated with poor patient outcome. GBM...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Ther Nucleic Acids
Auteurs principaux: Affinito, Alessandra, Quintavalle, Cristina, Esposito, Carla Lucia, Roscigno, Giuseppina, Giordano, Catello, Nuzzo, Silvia, Ricci-Vitiani, Lucia, Scognamiglio, Iolanda, Minic, Zoran, Pallini, Roberto, Berezovski, Maxim V., de Francisis, Vittorio, Condorelli, Gerolama
Format: Artigo
Langue:Inglês
Publié: American Society of Gene & Cell Therapy 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7068199/
https://ncbi.nlm.nih.gov/pubmed/32169805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2020.02.005
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires